Neoadjuvant therapy for breast cancer

Objective: To evaluate the frequency of neoadjuvant therapy (NT) in women with stage I–III breast cancer in Italy and whether it is influenced by biological characteristics, screening history, and geographic area. Methods: Data from the High Resolution Study conducted in 7 Italian cancer registries were used; they are a representative sample of incident cancers in the study period (2009–2013). Included were 3546 women aged Results: Only 8.2% of women (290 cases) underwent NT; the treatment decreases with increasing age (14.5% in age Conclusions: The use of NT in Italy is limited and variable. There are no signs of greater use in hospitals with more advanced care.